Nvidia Invests $50M into AI Drug Discovery Firm Recursion
In this episode, we delve into Nvidia's substantial $50M investment in Recursion, a leading firm in AI drug discovery. We'll explore the strategic implications of this partnership, discuss how it might accelerate the application of AI in pharmaceutical research, and consider its potential to revolutionize drug discovery.
Get on the AI Box Waitlist: https://AIBox.ai/
Investor Contact Email: [email protected]
Sponsor the Podcast: [email protected]
Facebook Community: https://www.facebook.com/groups/739308654562189/
Discord Community: https://aibox.ai/discord
Download Selfpause: https://selfpause.com/Podcast
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
You May Also Like

Emilcar Daily
Emilcar

ITSPmagazine
ITSPmagazine, Sean Martin, Marco Ciappelli

Al otro lado del micrófono
Jorge Marín Nieto - Editor de podcast en EOVE Productora

Machine Learning: News on AI, OpenAI, ChatGPT, Artificial Intelligence, AI Models
Machine Learning: News on AI, OpenAI, ChatGPT, Artificial Intelligence, AI Models

TBPN
John Coogan & Jordi Hays

Artificial Intelligence Masterclass
AI Masterclass

Jack Hopkins
Jack Hopkins

Macworld Podcast
Foundry

Tech&Co, la quotidienne
BFM Business

Security Weekly News (Audio)
Doug White
Community discussion